Statement from Norman E. "Ned" Sharpless MD, Acting Commissioner and Dr. Peter Marks M.D. PhD., Director - Center for Biologics Evaluation and Research (CBER)
As part of the U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud, the agency is reminding consumers to be wary of unapproved products claiming to prevent, treat or cure influenza, or flu.